Healthcare provider profile · identity verified

Patrick M Nunno, M.D.

Internal Medicine · FAIRPORT, NY · NPI 1972539351

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	774	246
Levothyroxine Sodium	Levothyroxine Sodium	697	204
Amlodipine Besylate	Amlodipine Besylate	511	147
Omeprazole	Omeprazole	348	115
Rosuvastatin Calcium	Rosuvastatin Calcium	338	105
Losartan Potassium	Losartan Potassium	329	105
Lisinopril	Lisinopril	325	106
Famotidine	Famotidine	276	93
Hydrochlorothiazide	Hydrochlorothiazide	256	83
Pravastatin Sodium	Pravastatin Sodium	249	73
Gabapentin	Gabapentin	192	63
Celecoxib	Celecoxib	190	61
Meloxicam	Meloxicam	190	67
Metformin Hcl	Metformin Hcl	182	60
Metoprolol Succinate	Metoprolol Succinate	179	72
Tamsulosin Hcl	Tamsulosin Hcl	176	65
Pantoprazole Sodium	Pantoprazole Sodium	167	53
Bupropion Xl	Bupropion Hcl	152	43
Zolpidem Tartrate	Zolpidem Tartrate	142	28
Ozempic	Semaglutide	139	21
Metformin Hcl Er	Metformin Hcl	137	46
Eliquis	Apixaban	136	36
Sertraline Hcl	Sertraline Hcl	135	42
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	132	64
Fluticasone Propionate	Fluticasone Propionate	128	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	117	19
Finasteride	Finasteride	114	33
Doxazosin Mesylate	Doxazosin Mesylate	110	34
Escitalopram Oxalate	Escitalopram Oxalate	110	34
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	105	25
Irbesartan	Irbesartan	103	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	95	22
Albuterol Sulfate Hfa	Albuterol Sulfate	92	42
Torsemide	Torsemide	92	32
Donepezil Hcl	Donepezil Hcl	84	27
Furosemide	Furosemide	82	34
Venlafaxine Hcl Er	Venlafaxine Hcl	81	18
Atenolol	Atenolol	80	27
Benazepril Hcl	Benazepril Hcl	77	22
Calcitonin-Salmon	Calcitonin,salmon,synthetic	77	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	77	26
Duloxetine Hcl	Duloxetine Hcl	73	24
Synthroid	Levothyroxine Sodium	72	18
Carvedilol	Carvedilol	71	22
Citalopram Hbr	Citalopram Hydrobromide	70	22
Spironolactone	Spironolactone	69	22
Trazodone Hcl	Trazodone Hcl	64	20
Glimepiride	Glimepiride	62	17
Simvastatin	Simvastatin	62	28
Buspirone Hcl	Buspirone Hcl	61	22
Januvia	Sitagliptin Phosphate	61	15
Insulin Lispro Kwikpen U-100	Insulin Lispro	57	suppressed
Amoxicillin	Amoxicillin	52	30
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	50	11
Esomeprazole Magnesium	Esomeprazole Magnesium	50	15
Lansoprazole	Lansoprazole	48	17
Propranolol Hcl Er	Propranolol Hcl	47	11
Ezetimibe	Ezetimibe	46	14
Fluoxetine Hcl	Fluoxetine Hcl	46	11
Allopurinol	Allopurinol	45	14
Hydroxyzine Hcl	Hydroxyzine Hcl	45	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	15
Warfarin Sodium	Warfarin Sodium	45	11
Memantine Hcl	Memantine Hcl	44	15
Azithromycin	Azithromycin	42	36
Jardiance	Empagliflozin	42	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	41	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	41	16
Methylprednisolone	Methylprednisolone	40	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	22
Pregabalin	Pregabalin	39	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	12
Oxybutynin Chloride Er	Oxybutynin Chloride	37	11
Repatha Sureclick	Evolocumab	37	suppressed
Trulicity	Dulaglutide	37	suppressed
Fenofibrate	Fenofibrate	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Chlorthalidone	Chlorthalidone	34	11
Montelukast Sodium	Montelukast Sodium	34	15
Valsartan	Valsartan	34	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	suppressed
Azelastine Hcl	Azelastine Hcl	33	13
Prednisone	Prednisone	33	24
Valacyclovir	Valacyclovir Hcl	33	suppressed
Felodipine Er	Felodipine	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	15
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	26
Eszopiclone	Eszopiclone	30	suppressed
Mometasone Furoate	Mometasone Furoate	29	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Alprazolam	Alprazolam	28	18
Baclofen	Baclofen	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	12
Nifedipine Er	Nifedipine	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	16
Nitroglycerin	Nitroglycerin	26	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	20
Farxiga	Dapagliflozin Propanediol	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	17
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Rizatriptan	Rizatriptan Benzoate	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	12
Cephalexin	Cephalexin	20	18
Glipizide Er	Glipizide	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	12
Alprazolam Xr	Alprazolam	17	suppressed
Diazepam	Diazepam	17	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Novofine 32	Pen Needle, Diabetic	16	suppressed
Potassium Chloride	Potassium Chloride	16	suppressed
Cefuroxime	Cefuroxime Axetil	15	12
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Procto-Med Hc	Hydrocortisone	15	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Nystatin	Nystatin	14	suppressed
Pioglitazone-Metformin	Pioglitazone Hcl/Metformin Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Unifine Pentips Plus	Pen Needle, Diabetic	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	13	13
Praluent Pen	Alirocumab	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Lactulose	Lactulose	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Striverdi Respimat	Olodaterol Hcl	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Lagevrio (Eua)	Molnupiravir	11	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error